Individualized optimization of the screening interval for diabetic retinopathy: A new model

Acta Ophthalmologica

Volumn 90, Issue 2, 2012, Pages 109-114

  Mehlsen, Jesper ^a   Erlandsen, Mogens ^b   Poulsen, Per Løgstrup ^a   Bek, Toke ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

causal inference; diabetic retinopathy; risk factors; screening interval; time dependent confounding

Indexed keywords

HEMOGLOBIN A1C;

ANALYTIC METHOD; ARTICLE; CALCULATION; DIABETIC RETINOPATHY; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; RETINA HEMORRHAGE; RISK FACTOR; SCREENING TEST; VALIDITY;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MASS SCREENING; MODELS, STATISTICAL; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84857753893     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2010.01882.x     Document Type: Article

References (24)

1. Bachmann MO, &, Nelson SJ, (1998): Impact of diabetic retinopathy screening on a British district population: case detection and blindness prevention in an evidence-based model. J Epidemiol Community Health 52: 45-52. (Pubitemid 28052603)
2. Chew EY, Klein ML, Ferris FL III, Remaley NA, Murphy RP, Chantry K, Hoogwerf BJ, &, Miller D, (1996): Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol 114: 1079-1084.
3. DCCT (1995): The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial. Arch Ophthalmol 113: 36-51.
4. Diggle P, Heagerty P, Liang K, &, Zeger S, (2002): Analysis of longitudinal data. New York: American Statistical Association.
5. Dobree JH, (1970): Simple diabetic retinopathy. Evolution of the lesions and therapeutic considerations. Br J Ophthalmol 54: 1-10.
6. Hove MN, Kristensen JK, Lauritzen T, &, Bek T, (2004): The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Arhus County, Denmark. Acta Ophthalmol Scand 82: 443-448. (Pubitemid 39199446)
7. Hove MN, Kristensen JK, Lauritzen T, &, Bek T, (2006): The relationships between risk factors and the distribution of retinopathy lesions in type 2 diabetes. Acta Ophthalmol Scand 84: 619-623. (Pubitemid 44317540)
8. Jensen FV, (1996): An introduction to Bayesian Networks. London: UCL Press.
9. Jeppesen P, &, Bek T, (2004): The occurrence and causes of registered blindness in diabetes patients in Arhus County, Denmark. Acta Ophthalmol Scand 82: 526-530. (Pubitemid 39386962)
10. Klein R, Klein BE, Moss SE, Davis MD, &, DeMets DL, (1988): Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 260: 2864-2871. (Pubitemid 18266031)
11. Klein R, Sharrett AR, Klein BE, et al., (2002): The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: the atherosclerosis risk in communities study. Ophthalmology 109: 1225-1234. (Pubitemid 34700911)
12. Knudsen LL, Lervang HH, Lundbye-Christensen S, &, Gorst-Rasmussen A, (2009): The North Jutland County Diabetic Retinopathy Study (NCDRS). Acta Ophthalmol: [Epub ahead of print]
13. Kohner EM, Stratton IM, Aldington SJ, Turner RC, &, Matthews DR, (1999): Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group. Diabetologia 42: 1107-1112. (Pubitemid 29408809)
14. Mehlsen J, Erlandsen M, Poulsen PL, &, Bek T, (2009): Identification of independent risk factors for the development of diabetic retinopathy requiring treatment. Acta Ophthalmol: [Epub ahead of print]
15. Olafsdottir E, &, Stefansson E, (2007): Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol 91: 1599-1601. (Pubitemid 350207380)
16. Patel S, Chen H, Tinkham NH, &, Zhang K, (2008): Genetic susceptibility of diabetic retinopathy. Curr Diab Rep 8: 257-262.
17. Robins JM, Hernan MA, &, Brumback B, (2000): Marginal structural models and causal inference in epidemiology. Epidemiology 11: 550-560. (Pubitemid 30660034)
18. Rohan TE, Frost CD, &, Wald NJ, (1989): Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment. BMJ 299: 1198-1201. (Pubitemid 19281168)
19. Singer DE, Nathan DM, Fogel HA, &, Schachat AP, (1992): Screening for diabetic retinopathy. Ann Intern Med 116: 660-671.
20. Stefansson E, Bek T, Porta M, Larsen N, Kristinsson JK, &, Agardh E, (2000): Screening and prevention of diabetic blindness. Acta Ophthalmol Scand 78: 374-385. (Pubitemid 30609364)
21. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, &, Matthews DR, (2001): UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 44: 156-163. (Pubitemid 32156199)
22. WHO (2008): Diabetes fact sheet no 312. Accessed dec 14. 2009.
23. Younis N, Broadbent DM, Harding SP, &, Vora JP, (2003a): Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme. Diabet Med 20: 758-765. (Pubitemid 41701472)
24. Younis N, Broadbent DM, Vora JP, &, Harding SP, (2003b): Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 361: 195-200. (Pubitemid 36126218)